Literature DB >> 17999633

Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?

Chao Lu1, Dawei Zhang, Matthew Whiteman, Jeffrey S Armstrong.   

Abstract

MitoQ has been developed as a mitochondrial targeted antioxidant for diseases associated with oxidative stress. Here we show that MitoQ blocks the generation of reactive oxygen species (ROS) and mitochondrial protein thiol oxidation, and preserves mitochondrial function and ultrastructure after glutathione (GSH) depletion. Furthermore, the antioxidant effect of MitoQ is conserved in cells lacking mitochondrial DNA, indicating that its antioxidant properties do not depend on a functional electron transport chain (ETC). Our results elucidate the antioxidant mechanism of MitoQ and suggest that it may be a useful therapeutic for disorders associated with a dysfunctional ETC and increased ROS production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17999633     DOI: 10.1089/ars.2007.1865

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  18 in total

Review 1.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

2.  Frontiers in Alzheimer's disease therapeutics.

Authors:  Jeremy G Stone; Gemma Casadesus; Kasia Gustaw-Rothenberg; Sandra L Siedlak; Xinglong Wang; Xiongwei Zhu; George Perry; Rudy J Castellani; Mark A Smith
Journal:  Ther Adv Chronic Dis       Date:  2011-01-01       Impact factor: 5.091

Review 3.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 4.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

Review 5.  The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Authors:  Junghee Lee; Jung Hyun Boo; Hoon Ryu
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

Review 6.  Mitochondria: a therapeutic target in neurodegeneration.

Authors:  Paula I Moreira; Xiongwei Zhu; Xinglong Wang; Hyoung-Gon Lee; Akihiko Nunomura; Robert B Petersen; George Perry; Mark A Smith
Journal:  Biochim Biophys Acta       Date:  2009-10-21

Review 7.  Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass.

Authors:  David J Bonda; Xinglong Wang; Hyoung-Gon Lee; Mark A Smith; George Perry; Xiongwei Zhu
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

Review 8.  Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?

Authors:  Bo Su; Xinglong Wang; David Bonda; Gorge Perry; Mark Smith; Xiongwei Zhu
Journal:  Mol Neurobiol       Date:  2010-01-27       Impact factor: 5.590

Review 9.  Mechanisms associated with the dysregulation of mitochondrial function due to lead exposure and possible implications on the development of Alzheimer's disease.

Authors:  Lakshmi Jaya Madhuri Bandaru; Neelima Ayyalasomayajula; Lokesh Murumulla; Suresh Challa
Journal:  Biometals       Date:  2022-01-20       Impact factor: 2.949

10.  MitoQ blunts mitochondrial and renal damage during cold preservation of porcine kidneys.

Authors:  Nirmala Parajuli; Lia H Campbell; Akira Marine; Kelvin G M Brockbank; Lee Ann Macmillan-Crow
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.